Nusaiba N Ahmed, Riley G Young, Jessica Merzy, Mauricio J Reginato
{"title":"Sugar storm: O-GlcNAc signaling amid the clouds of cancer complexity.","authors":"Nusaiba N Ahmed, Riley G Young, Jessica Merzy, Mauricio J Reginato","doi":"10.1093/glycob/cwag026","DOIUrl":null,"url":null,"abstract":"<p><p>Cancer is a systemic disease driven not only by cell-intrinsic alterations, but also by system-wide factors that regulate its initiation and progression. Among the key regulators of these processes are nutrient-sensing pathways, which coordinate both cellular and systemic responses. One such pathway involves O-linked N-acetylglucosaminylation (O-GlcNAcylation), a nutrient-responsive and reversible post-translational modification that has emerged as a critical driver of cancer progression. Catalyzed by O-GlcNAc transferase (OGT), O-GlcNAcylation integrates signals from glucose, glutamine, and other nutrients to regulate the activity of cytoplasmic, nuclear, and mitochondrial proteins. Recent studies demonstrate that O-GlcNAcylation influences multiple dimensions of cancer progression, including metabolic adaptation, transcriptional plasticity, immune evasion, metastasis, cancer stem-like states, and therapy resistance. Beyond its cell-intrinsic effects, O-GlcNAcylation also interfaces with broader systemic processes. In this review, we position O-GlcNAcylation within the framework of the \"clouds of cancer complexity,\" highlighting its roles across the metabolic effects, inception and promotion, pleiotropic immune responses, and aging systems and tissues clouds. We propose that O-GlcNAcylation functions as a systems-level integrator that embeds metabolic, environmental, and temporal signals into tumor evolution, revealing new conceptual and therapeutic opportunities.</p>","PeriodicalId":12766,"journal":{"name":"Glycobiology","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Glycobiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1093/glycob/cwag026","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Cancer is a systemic disease driven not only by cell-intrinsic alterations, but also by system-wide factors that regulate its initiation and progression. Among the key regulators of these processes are nutrient-sensing pathways, which coordinate both cellular and systemic responses. One such pathway involves O-linked N-acetylglucosaminylation (O-GlcNAcylation), a nutrient-responsive and reversible post-translational modification that has emerged as a critical driver of cancer progression. Catalyzed by O-GlcNAc transferase (OGT), O-GlcNAcylation integrates signals from glucose, glutamine, and other nutrients to regulate the activity of cytoplasmic, nuclear, and mitochondrial proteins. Recent studies demonstrate that O-GlcNAcylation influences multiple dimensions of cancer progression, including metabolic adaptation, transcriptional plasticity, immune evasion, metastasis, cancer stem-like states, and therapy resistance. Beyond its cell-intrinsic effects, O-GlcNAcylation also interfaces with broader systemic processes. In this review, we position O-GlcNAcylation within the framework of the "clouds of cancer complexity," highlighting its roles across the metabolic effects, inception and promotion, pleiotropic immune responses, and aging systems and tissues clouds. We propose that O-GlcNAcylation functions as a systems-level integrator that embeds metabolic, environmental, and temporal signals into tumor evolution, revealing new conceptual and therapeutic opportunities.
期刊介绍:
Established as the leading journal in the field, Glycobiology provides a unique forum dedicated to research into the biological functions of glycans, including glycoproteins, glycolipids, proteoglycans and free oligosaccharides, and on proteins that specifically interact with glycans (including lectins, glycosyltransferases, and glycosidases).
Glycobiology is essential reading for researchers in biomedicine, basic science, and the biotechnology industries. By providing a single forum, the journal aims to improve communication between glycobiologists working in different disciplines and to increase the overall visibility of the field.